By Dennis Thompson HealthDay ReporterTUESDAY, Jan. 13, 2026 (HealthDay News) — A simple blood test can predict a person’s ...

"What should I eat?" is perhaps the most common question patients with inflammatory bowel disease ask their doctors.

Researchers have identified a specific dietary program that successfully lessens the severe symptoms of a chronic digestive ...

A simple blood test can predict who will suffer from a debilitating bowel disease later in life, paving the way for early ...

A chronic condition affecting about a million Americans, Crohn's disease causes inflammation in the digestive tract, leading ...

Early-stage biotech NeuroScientific Biopharmaceuticals has delivered real-world promise for those living with chronic Crohn’s ...

The Texas Department of Public Safety has issued provisional licenses to nine new medical marijuana operators while existing ...

Tremfya and Icotide are touted as key growth drivers in J&J’s strongly performing innovative medicines business.

The ASX closed out another convincing day of gains in today’s trade, climbing on rallies in a broad basket of ... Read More ...

NeuroScientific Biopharmaceuticals (ASX: NSB) has confirmed that 75% of patients in the first cohort of a study into its ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...